The intersection of CBD (cannabidiol) and the tobacco industry is evolving rapidly, with the potential rescheduling of cannabis from Schedule I to Schedule III expected to reshape how CBD is integrated into tobacco products. At the same time, consumer demand for CBD-infused cigarettes and alternatives to nicotine has grown significantly, signaling a shift in the way both industries may operate in the coming years.

Rescheduling Cannabis: What It Means for CBD and the Tobacco Industry

The push to reschedule cannabis under U.S. federal law primarily targets marijuana-based products, but it has wide-reaching implications for hemp-derived CBD as well. Currently, CBD derived from hemp (which contains low THC levels) is legal under the 2018 Farm Bill. However, rescheduling cannabis to a lower category could reduce regulatory obstacles and clarify how CBD products, including those infused into tobacco, are handled legally.

While marijuana will remain restricted from being added to food or tobacco products after rescheduling, CBD from hemp may benefit from the change. This could potentially open the door for a broader market for CBD-infused smoking products, as regulators develop clearer guidelines around CBD’s inclusion in consumer goods like cigarettes. However, products that blend CBD and tobacco will still need to comply with FDA regulations, and manufacturers will be required to demonstrate that these products are safe for consumption​.

The Rising Demand for CBD in Tobacco Products

As traditional cigarette sales continue to decline due to health concerns and changes in consumer preferences, the tobacco industry is exploring new ways to innovate. One promising avenue is the creation of CBD-infused tobacco products. CBD cigarettes, often made with hemp flower instead of tobacco, are gaining popularity, especially among smokers looking for an alternative to nicotine.

CBD, known for its calming properties and potential to reduce stress, offers an appealing alternative for users who are seeking a healthier, non-addictive smoking experience. Many consumers are turning to CBD cigarettes as a way to alleviate anxiety, stress, and pain without the addictive qualities associated with nicotine.(

MMJ.com).

The CBD cigarette market is expected to grow substantially over the next few years, with a projected compound annual growth rate (CAGR) of 30.5% from 2024 to 2030. This surge in demand is not just limited to the U.S.; markets in Europe and other regions where hemp-derived CBD is legal are also seeing increased interest in CBD-infused smoking products.

CBD’s Integration into Tobacco Accessories

Alongside the rise of CBD cigarettes, the market for tobacco accessories such as rolling papers, pipes, and lighters has also seen growth, particularly in regions where cannabis and CBD are legalized. Retailers are increasingly offering a variety of products tailored to consumers looking to incorporate CBD into their smoking habits. Hemp-derived CBD products, including low-dose CBD cigarettes, are becoming popular in convenience stores and other retail outlets.

This trend reflects a broader shift in consumer preferences, where people are looking for natural alternatives to traditional smoking products, especially as e-cigarettes and nicotine pouches chip away at traditional cigarette sales​. By offering a range of CBD-infused smoking products and accessories, retailers are able to tap into this growing segment of health-conscious consumers.

The global cannabidiol market (CBD) is set to undergo a dramatic expansion, with projections estimating the market value will grow from USD 8.12 billion in 2024 to USD 23.41 billion by 2031. This represents a compound annual growth rate (CAGR) of 16.3% over the forecast period. The rise in demand for CBD products, coupled with increasing legalization worldwide, and the growing acceptance of CBD in both the health and wellness sectors, are the primary drivers of this growth.

Why the Cannabidiol Market Will Surge 16.3% by 2031 – Market Drivers and Dynamics

The global Cannabidiol market is witnessing growth across multiple fronts, with several factors playing a crucial role:

Legalization and Regulatory Evolution

Legalization in North America, Europe, and parts of Asia-Pacific has provided the foundation for CBD’s widespread adoption. The 2018 U.S. Farm Bill, which legalized hemp-derived CBD with less than 0.3% THC, has accelerated market growth in North America, accounting for a 40.2% market share in 2024​. Europe is expected to follow suit as more countries, including Germany and the UK, adjust their regulations around medical CBD, contributing to rapid market expansion.

In Asia-Pacific, countries like China, Japan, and India are showing interest in hemp-derived CBD, contributing to the region’s position as the fastest-growing market. The increasing recognition of CBD’s health benefits has led to expanding domestic production and a regulatory shift toward greater acceptance​.

Increasing Demand for Natural Health and Wellness Products

The rising trend toward natural, plant-based health solutions is a major driver of CBD demand. Consumers are increasingly seeking alternatives to traditional pharmaceuticals for managing conditions like chronic pain, anxiety, and sleep disorders. CBD products are perceived as safer, non-addictive options compared to opioids and benzodiazepines, which has contributed to their growing popularity.

CBD is also being adopted in the sports and fitness sectors, with athletes and active individuals using it for its anti-inflammatory and pain-relieving properties. This crossover into wellness and fitness markets is expected to fuel continued growth, particularly for CBD oils, topicals, and edibles.

Medical and Therapeutic Applications

CBD’s use in medical treatments is a key segment driving growth. The pharmaceutical industry is increasingly incorporating CBD into medications, with FDA-approved products like Epidiolex used to treat epilepsy. CBD’s role in treating conditions like schizophrenia, multiple sclerosis, chronic pain, and even cancer symptoms has opened up significant opportunities for expansion in the medical cannabis market​.

Research continues to explore CBD’s potential in treating opioid addiction, neurological disorders, and mental health conditions, making the medical sector one of the most promising growth avenues​.

Market Segmentation: Product and Application Insights

The cannabidiol market is diverse, with products catering to a wide range of consumer needs. The market can be segmented by product type, application, and region:

By Product Type

• CBD Oil: Accounting for the largest market share, CBD oil is favored for its bioavailability and versatility. It can be administered sublingually, added to food and drinks, or used topically.
• Topicals: CBD topicals, such as creams and balms, are gaining popularity for their effectiveness in treating localized pain, skin conditions, and inflammation​.
• Edibles and Beverages: The growing popularity of CBD-infused food and drinks is particularly strong in North America and Europe. This segment appeals to a broader consumer base looking for convenient and discreet consumption methods​.

By Application

• Medical Use: Medical CBD applications, particularly in managing chronic pain, neurological disorders, and epilepsy, are a major growth driver. This segment is expected to continue expanding as research confirms more therapeutic benefits​.
• Wellness and Personal Use: The wellness market has seen significant growth, with consumers using CBD for stress relief, sleep improvement, and general well-being. CBD-infused skincare and beauty products are also becoming increasingly popular.

Regional Insights: Market Growth Across Continents

North America

The North American market dominates the global CBD landscape, driven by favorable regulations and strong consumer demand. The U.S. remains the largest market, with major players like CV Sciences and Charlotte’s Web leading the industry. Canada has also seen significant growth due to nationwide legalization of cannabis.

2. Europe

Europe is projected to witness steady growth as countries such as Germany, the UK, and France develop more favorable regulatory frameworks. Increased demand for CBD in pharmaceuticals and wellness products will fuel market growth.

Asia-Pacific

The Asia-Pacific region is set to emerge as the fastest-growing market due to its vast population and increasing demand for hemp-derived CBD products. China and Japan, in particular, are investing in domestic hemp production, positioning themselves as key players in the CBD supply chain​.

Challenges and Opportunities in the Cannabidiol Market

Despite the promising growth trajectory, the cannabidiol market faces several challenges:

1. Regulatory Uncertainty

The lack of uniform global regulations creates barriers to entry for manufacturers and complicates international trade. In countries where cannabis remains illegal or heavily regulated, businesses face hurdles in scaling operations and distributing products across borders.

2. Quality and Safety Concerns

As demand for CBD products grows, ensuring product quality and safety becomes increasingly important. The rise of counterfeit and contaminated products in unregulated markets can undermine consumer trust, emphasizing the need for clear regulations and third-party testing.

3. Product Innovation and Differentiation

With intense competition in the market, companies are focusing on product innovation to stand out. Developing new forms of CBD delivery, such as CBD inhalers, transdermal patches, and suppositories, will create opportunities for differentiation and attract niche markets​.

Conclusion

The global CBD market is set for extraordinary growth through 2031, driven by expanding legalization, increasing consumer interest in natural health products, and advancements in medical applications. With a projected CAGR of 16.3%, the market presents significant opportunities for businesses and investors. However, companies must navigate regulatory complexities and ensure product quality to achieve long-term success.

Like this:

Like Loading…

Related

Roughly 19% of the people suffer from joint pain – a daily struggle…but here is how medical marijuana can help.

Roughly 19% suffer from joint pain or some part of arthritis. Not only is it painful, it is disruptive in daily life. Some pain can be short term, like from sprains, an injury, tendinitis, or tendon inflammation, an infection of the bone or joint, or overuse of a joint. But some can be long term issues with an impact the patients like. Arthritis, fibromyalgia, osteoporosis, bursitis, lupus and more can be long, lingering issues with pain. There is some hope, and cannabis might be one.  Here is key information about joint pain and medical marijuana.

RELATED: What’s Next For Rheumatoid Arthritis And Cannabis?

One study concluded about 20% of patients with rheumatoid diseases who actively consume cannabis report an improvement in pain. Cannabis contains key components which help reduce inflammation.  More research needs to be done to to perfect treatment and dosage, but early indicators look positive for help. Another current benefit of medical marijuana or CBD with joint pain, is it helps with sleep, which is a problem with people in chronic pain.

Medical marijuana, in the right dose can also be easier on the body. Long used as a natural pain killer, it is less addictive and the body responds positively.  Currently used, orticosteroid injections have been a staple in managing pain and inflammation. With new research showcasing the long-term effects of one of the most used treatments, doctors and researchers are concerned about the risks of injections and the potential risks involved with cortisone. 

RELATED: Dear Dr. Green: Can Marijuana Topicals Help With Arthritis?

A Boston University study found patients who had been given the medicine by injection found a risk for “accelerated adverse joint events after treatment.” Meaning, when a patient was treated for osteoarthritis or other joint pain via a shot of cortisone, it may have accelerated joint destruction and bone loss. The study also found certain preexisting conditions, such as older age and Caucasian race seemed to increase the risk for the outcome even more. Researchers recommended MRI pre-screening before injections were given to identify the area better and find if the danger could be accurately assessed before the dose was given. 

Not only can medical marijuana be helpful, but so can CBD. The Arthritis Foundation has a guide to CBD for those that suffer from the condition. According to Dr. Daniel Clauw, a contributor to the guide, “Right now, it (CBD) appears to be fairly safe and might help certain types of pain.” 

While CBD and THC can be used as part of a pain management regimen, they currently can not be the entire plan. Studies like the one conducted on cortisone treatments are bringing the conversations of cannabis and CBD to greater light and offering less stigmatization, but until more research is done, the best path for joint pain is still unknown.